{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:03:36Z","timestamp":1789193016773,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research (RQ)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.06.030","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T04:40:53Z","timestamp":1311655253000},"page":"200-208","source":"Crossref","is-referenced-by-count":60,"title":["Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety"],"prefix":"10.1016","volume":"62","author":[{"given":"Julio C\u00e9sar","family":"Morales-Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Etienne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bastianetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Quirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.06.030_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jn\/136.1.195","article-title":"PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice","volume":"136","author":"Adams","year":"2006","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib2","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.peptides.2006.07.020","article-title":"Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze","volume":"27","author":"Bacchi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0893-133X(00)00231-1","article-title":"Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior","volume":"25","author":"Caberlotto","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:28:3:239","article-title":"Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice","volume":"28","author":"Carvajal","year":"2006","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib68","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1523\/JNEUROSCI.22-20-08922.2002","article-title":"Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1","volume":"22","author":"Chavez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.peptides.2004.01.013","article-title":"Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides","volume":"25","author":"Dumont","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1523\/JNEUROSCI.18-15-05565.1998","article-title":"Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain","volume":"18","author":"Dumont","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2","article-title":"Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains","volume":"402","author":"Dumont","year":"1998","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3565(25)24459-7","article-title":"Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands","volume":"272","author":"Dumont","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib10","series-title":"Peptide Receptors, Part 1","first-page":"375","article-title":"Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brain","author":"Dumont","year":"2000"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib11","series-title":"Transmitters and Modulators in Health and Disease","first-page":"51","article-title":"Neuropeptide Y an its role in anxiety-related disorders","author":"Dumont","year":"2009"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.105.089300","article-title":"Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain","volume":"315","author":"Dumont","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0702983","article-title":"[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors","volume":"129","author":"Dumont","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib14","series-title":"Progress in Inflammation Research","first-page":"7","article-title":"An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization","author":"Dumont","year":"2006"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(80)90012-6","article-title":"The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs","volume":"2","author":"File","year":"1980","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A\u00a0review of 25 years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur. J.\u00a0Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/jm00168a014","article-title":"Structural study of the N-terminal segment of neuropeptide tyrosine","volume":"33","author":"Forest","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2009.02.033","article-title":"Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors","volume":"1266","author":"Goyal","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-004-2122-1","article-title":"Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study","volume":"179","author":"Hasegawa","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism","volume":"38","author":"Heilig","year":"2004","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib62","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jm970512x","article-title":"Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists","volume":"40","author":"Hipskind","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1615\/CritRevNeurobiol.v15.i2.30","article-title":"Rodent models of depression: reexamining validity without anthropomorphic inference","volume":"15","author":"Holmes","year":"2003","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00029-3","article-title":"Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory\/limbic system","volume":"86","author":"Holmes","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2006.04.026","article-title":"CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder","volume":"1095","author":"Hou","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2004.09.001","article-title":"Contrasting grooming phenotypes in C57Bl\/6 and 129S1\/SvImJ mice","volume":"1028","author":"Kalueff","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.118.6.1365","article-title":"Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats","volume":"118","author":"Kalynchuk","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-9384(00)00374-7","article-title":"High social anxiety and low aggression in Fawn-Hooded rats","volume":"71","author":"Kantor","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(01)00768-3","article-title":"Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat","volume":"414","author":"Kask","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"The olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","article-title":"Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices","volume":"73","author":"King","year":"1999","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib65","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(00)00230-2","article-title":"Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release","volume":"396","author":"King","year":"2000","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0306-4522(03)00555-4","article-title":"Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles","volume":"121","author":"Liu","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib33","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1073\/pnas.0705615105","article-title":"Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy","volume":"105","author":"Mitra","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib34","unstructured":"Morales-Medina, J., Juarez, I., Venancio-Garc\u00eda, E., Cabrera, S., Flores, G., Menard, C., Quirion, R., 2010a. Major morphological reorganization of key brain regions in the olfactory bulbectomized rat Canadian neuroscience meeting."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A\u00a0possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib36","series-title":"Neurobiology of Depression","article-title":"Role of neuropeptide Y in depression: current status","author":"Morales-Medina","year":"2011"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.peptides.2009.04.006","article-title":"Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice","volume":"30","author":"Moriya","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib38","article-title":"Animal models of depression and anxiety: what do they tell\u00a0us\u00a0about human condition?","author":"Neumann","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2008.05.004","article-title":"Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice","volume":"55","author":"Painsipp","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib70","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","article-title":"Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice","volume":"7","author":"Painsipp","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib39","doi-asserted-by":"crossref","unstructured":"Pandey, D.K., Mahesh, R., Kumar, A.A., Rao, V.S., Arjun, M., Rajkumar, R. A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol. Biochem. Behav. 94:363\u2013373.","DOI":"10.1016\/j.pbb.2009.09.018"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib40","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0091-3057(00)00358-0","article-title":"Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures","volume":"67","author":"Primeaux","year":"2000","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2009.02.041","article-title":"1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay","volume":"608","author":"Rajkumar","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib45","first-page":"121","article-title":"Characterization of Neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing","volume":"22","author":"Redrobe","year":"2003","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(02)00374-1","article-title":"Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice","volume":"141","author":"Redrobe","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.peptides.2009.12.015","article-title":"Behavioral effects of neuropeptides in rodent models of depression and anxiety","volume":"31","author":"Rotzinger","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(02)03136-0","article-title":"Regulation of neuropeptide Y in the rat amygdala following unilateral olfactory bulbectomy","volume":"951","author":"Rutkoski","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(01)00679-7","article-title":"Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala","volume":"71","author":"Sajdyk","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/brbi.1996.0001","article-title":"The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression","volume":"10","author":"Song","year":"1996","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"Sorensen","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib54","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jnr.20620","article-title":"Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression","volume":"82","author":"Tanaka","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib71","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.neuroscience.2008.11.048","article-title":"Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice","volume":"158","author":"Tasan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y\u2013a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbr.2008.10.006","article-title":"Neuropeptides in depression: role of VGF","volume":"197","author":"Thakker-Varia","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00001756-199902250-00020","article-title":"Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety","volume":"10","author":"To","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"Tschenett","year":"2003","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.neuropharm.2011.06.030_bib58","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","article-title":"The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity","volume":"328","author":"Walker","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbr.2007.01.003","article-title":"Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety","volume":"178","author":"Wang","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.2003.01702.x","article-title":"Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study","volume":"85","author":"Watanabe","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","article-title":"Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively","volume":"22","author":"Widerlov","year":"1988","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.06.030_bib74","doi-asserted-by":"crossref","first-page":"R868","DOI":"10.1152\/ajpregu.00213.2006","article-title":"Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent","volume":"292","author":"Zhang","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:25:26Z","timestamp":1741350326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811003005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811003005"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}